| Publications | PubMed=4811796; DOI=10.7326/0003-4819-80-2-221
Robbins J.H., Kraemer K.H., Lutzner M.A., Festoff B.W., Coon H.G.
Xeroderma pigmentosum. An inherited disease with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair.
Ann. Intern. Med. 80:221-248(1974) PubMed=837385
Lehmann A.R., Kirk-Bell S., Arlett C.F., Harcourt S.A., de Weerd-Kastelein E.A., Keijzer W., Hall-Smith P.
Repair of ultraviolet light damage in a variety of human fibroblast cell strains.
Cancer Res. 37:904-910(1977) PubMed=273925; DOI=10.1073/pnas.75.4.1984; PMCID=PMC392467
Andrews A.D., Barrett S.F., Robbins J.H.
Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation.
Proc. Natl. Acad. Sci. U.S.A. 75:1984-1988(1978) PubMed=656543; DOI=10.1016/S0006-3495(78)85487-3; PMCID=PMC1473442
Ehmann U.K., Cook K.H., Friedberg E.C.
The kinetics of thymine dimer excision in ultraviolet-irradiated human cells.
Biophys. J. 22:249-264(1978) PubMed=225015
Hall J.D., Tokuno S.-i.
Enhanced transformation of xeroderma pigmentosum variant cells by ultraviolet light-irradiated simian virus 40.
Cancer Res. 39:4064-4068(1979) PubMed=503099; DOI=10.1016/0027-5107(79)90089-7
Myhr B.C., Turnbull D., DiPaolo J.A.
Ultraviolet mutagenesis of normal and xeroderma pigmentosum variant human fibroblasts.
Mutat. Res. 62:341-353(1979) PubMed=6947227; DOI=10.1073/pnas.78.10.6236; PMCID=PMC349013
Miskin R., Ben-Ishai R.
Induction of plasminogen activator by UV light in normal and xeroderma pigmentosum fibroblasts.
Proc. Natl. Acad. Sci. U.S.A. 78:6236-6240(1981) PubMed=7273335; DOI=10.1093/carcin/2.6.567
Simon L., Hazard R.M., Maher V.M., McCormick J.J.
Enhanced cell killing and mutagenesis by ethylnitrosourea in xeroderma pigmentosum cells.
Carcinogenesis 2:567-570(1981) PubMed=6409440; DOI=10.1093/carcin/4.7.911
Smith P.J., Greene M.H., Adams D., Paterson M.C.
Abnormal responses to the carcinogen 4-nitroquinoline 1-oxide of cultured fibroblasts from patients with dysplastic nevus syndrome and hereditary cutaneous malignant melanoma.
Carcinogenesis 4:911-916(1983) PubMed=3932847; DOI=10.1016/0167-8817(85)90070-7
Watanabe M., Maher V.M., McCormick J.J.
Excision repair of UV- or benzo[a]pyrene diol epoxide-induced lesions in xeroderma pigmentosum variant cells is 'error free'.
Mutat. Res. 146:285-294(1985) PubMed=10385124; DOI=10.1038/21447
Masutani C., Kusumoto R., Yamada A., Dohmae N., Yokoi M., Yuasa M., Araki M., Iwai S., Takio K., Hanaoka F.
The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta.
Nature 399:700-704(1999) PubMed=11773631; DOI=10.1073/pnas.022473899; PMCID=PMC117388
Broughton B.C., Cordonnier A.M., Kleijer W.J., Jaspers N.G.J., Fawcett H., Raams A., Garritsen V.H., Stary A., Avril M.-F., Boudsocq F., Masutani C., Hanaoka F., Fuchs R.P.P., Sarasin A., Lehmann A.R.
Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients.
Proc. Natl. Acad. Sci. U.S.A. 99:815-820(2002) PubMed=17409408; DOI=10.1158/0008-5472.CAN-06-3073
Wang Y., Woodgate R., McManus T.P., Mead S., McCormick J.J., Maher V.M.
Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations.
Cancer Res. 67:3018-3026(2007) |
|---|
